Published in J Gen Physiol on July 01, 2001
Functional and structural conservation of CBS domains from CLC chloride channels. J Physiol (2004) 1.67
Conformational changes in the pore of CLC-0. J Gen Physiol (2003) 1.66
Side-chain charge effects and conductance determinants in the pore of ClC-0 chloride channels. J Gen Physiol (2003) 1.58
Interaction of acid-sensing ion channel (ASIC) 1 with the tarantula toxin psalmotoxin 1 is state dependent. J Gen Physiol (2006) 1.51
Involvement of helices at the dimer interface in ClC-1 common gating. J Gen Physiol (2003) 1.49
Quantitative analysis of the voltage-dependent gating of mouse parotid ClC-2 chloride channel. J Gen Physiol (2005) 1.42
Gating competence of constitutively open CLC-0 mutants revealed by the interaction with a small organic Inhibitor. J Gen Physiol (2003) 1.41
Drastic reduction of the slow gate of human muscle chloride channel (ClC-1) by mutation C277S. J Physiol (2001) 1.20
Molecular determinants of differential pore blocking of kidney CLC-K chloride channels. EMBO Rep (2004) 1.09
Blocking pore-open mutants of CLC-0 by amphiphilic blockers. J Gen Physiol (2008) 0.89
Taurine: the appeal of a safe amino acid for skeletal muscle disorders. J Transl Med (2015) 0.85
Amphiphilic blockers punch through a mutant CLC-0 pore. J Gen Physiol (2008) 0.85
ClC-1 chloride channels: state-of-the-art research and future challenges. Front Cell Neurosci (2015) 0.84
Structural requisites of 2-(p-chlorophenoxy)propionic acid analogues for activity on native rat skeletal muscle chloride conductance and on heterologously expressed CLC-1. Br J Pharmacol (2003) 0.82
Inhibition of ClC-2 chloride channels by a peptide component or components of scorpion venom. J Membr Biol (2005) 0.81
Open-state substructure of single chloride channels from Torpedo electroplax. Philos Trans R Soc Lond B Biol Sci (1982) 5.26
Gating of the voltage-dependent chloride channel CIC-0 by the permeant anion. Nature (1995) 4.27
Nonequilibrium gating and voltage dependence of the ClC-0 Cl- channel. J Gen Physiol (1996) 4.24
Primary structure and functional expression of a developmentally regulated skeletal muscle chloride channel. Nature (1991) 3.62
Two physically distinct pores in the dimeric ClC-0 chloride channel. Nature (1996) 3.58
Mechanism of charybdotoxin block of the high-conductance, Ca2+-activated K+ channel. J Gen Physiol (1988) 3.48
Homodimeric architecture of a ClC-type chloride ion channel. Nature (1996) 3.47
Concentration and pH dependence of skeletal muscle chloride channel ClC-1. J Physiol (1996) 2.37
Low single channel conductance of the major skeletal muscle chloride channel, ClC-1. Biophys J (1994) 2.28
The muscle chloride channel ClC-1 has a double-barreled appearance that is differentially affected in dominant and recessive myotonia. J Gen Physiol (1999) 2.17
Permeation and block of the skeletal muscle chloride channel, ClC-1, by foreign anions. J Gen Physiol (1998) 2.02
The CLC chloride channel family. Pflugers Arch (1999) 1.95
Temperature dependence of fast and slow gating relaxations of ClC-0 chloride channels. J Gen Physiol (1997) 1.92
Elimination of the slow gating of ClC-0 chloride channel by a point mutation. J Gen Physiol (1999) 1.89
A decade of CLC chloride channels: structure, mechanism, and many unsettled questions. Annu Rev Biophys Biomol Struct (2000) 1.89
Fast and slow gating relaxations in the muscle chloride channel CLC-1. J Gen Physiol (2000) 1.73
Analysis of a protein region involved in permeation and gating of the voltage-gated Torpedo chloride channel ClC-0. J Physiol (1997) 1.50
Projection structure of a ClC-type chloride channel at 6.5 A resolution. Nature (2001) 1.41
Pharmacological characterization of chloride channels belonging to the ClC family by the use of chiral clofibric acid derivatives. Mol Pharmacol (2000) 1.24
Independent gating of single pores in CLC-0 chloride channels. Biophys J (1997) 1.20
Enantiomers of clofibric acid analogs have opposite actions on rat skeletal muscle chloride channels. Pflugers Arch (1988) 1.14
Pore stoichiometry of a voltage-gated chloride channel. Nature (1998) 1.12
Identification of functionally important regions of the muscular chloride channel CIC-1 by analysis of recessive and dominant myotonic mutations. Hum Mol Genet (1997) 1.11
The block of Shaker K+ channels by kappa-conotoxin PVIIA is state dependent. J Gen Physiol (1999) 1.09
Interaction between quaternary ammonium ions in the pore of potassium channels. Evidence against an electrostatic repulsion mechanism. J Gen Physiol (2000) 1.04
Modulation of the gating of CIC-1 by S-(-) 2-(4-chlorophenoxy) propionic acid. Br J Pharmacol (1999) 1.00
Opposite effects of enantiomers of clofibric acid derivative on rat skeletal muscle chloride conductance: antagonism studies and theoretical modeling of two different receptor site interactions. J Pharmacol Exp Ther (1992) 0.95
Chloride channels of skeletal muscle from developing, adult and aged rats are differently affected by enantiomers of 2-(p-chlorophenoxy) propionic acid. Naunyn Schmiedebergs Arch Pharmacol (1992) 0.82
Structural parts involved in activation and inactivation of the sodium channel. Nature (1989) 8.72
Inhibition of Bax channel-forming activity by Bcl-2. Science (1997) 5.10
Single channel recordings of K+ currents in squid axons. Nature (1980) 4.48
Potassium and sodium ion current noise in the membrane of the squid giant axon. J Physiol (1975) 4.03
Measurement of the conductance of the sodium channel from current fluctuations at the node of Ranvier. J Physiol (1976) 3.46
Mapping the site of block by tetrodotoxin and saxitoxin of sodium channel II. FEBS Lett (1991) 3.29
The steady state properties of ion exchange membranes with fixed sites. Biophys J (1965) 3.23
Subthreshold behavior and phenomenological impedance of the squid giant axon. J Gen Physiol (1970) 3.02
Channel noise in nerve membranes and lipid bilayers. Q Rev Biophys (1975) 2.67
Nonstationary noise analysis and application to patch clamp recordings. Methods Enzymol (1992) 2.60
European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis (2001) 2.49
Pursuing the structure and function of voltage-gated channels. Trends Neurosci (1990) 2.47
European guidelines on the clinical management of HIV-1 tropism testing. Lancet Infect Dis (2011) 2.47
Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma. J Natl Cancer Inst (1998) 2.32
PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc Natl Acad Sci U S A (1994) 2.29
Gating currents of inactivating and non-inactivating potassium channels expressed in Xenopus oocytes. Pflugers Arch (1991) 2.28
Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 2.24
The muscle chloride channel ClC-1 has a double-barreled appearance that is differentially affected in dominant and recessive myotonia. J Gen Physiol (1999) 2.17
Conductance of the sodium channel in myelinated nerve fibres with modified sodium inactivation. J Physiol (1976) 2.15
The steady-state properties of an ion exchange membrane with mobile sites. Biophys J (1966) 2.09
Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res (1997) 2.05
Failure of low-dose dapsone-pyrimethamine in primary prophylaxis of Pneumocystis carinii pneumonia. Lancet (1992) 1.81
Determinants of survival in progressive multifocal leukoencephalopathy. Neurology (2009) 1.77
Conductance fluctuations from the inactivation process of sodium channels in myelinated nerve fibres. J Physiol (1980) 1.75
Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment. Endocr Relat Cancer (2003) 1.67
Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs. Am J Transplant (2009) 1.65
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology (2011) 1.65
Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure. HIV Med (2011) 1.64
The magnetic field of an isolated neutron star from X-ray cyclotron absorption lines. Nature (2003) 1.63
Molecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies: new imaging strategies to guide molecular therapies. Eur J Nucl Med Mol Imaging (2009) 1.62
Activation and inactivation of homomeric KvLQT1 potassium channels. Biophys J (1998) 1.61
The ErbB receptors and their ligands in cancer: an overview. Curr Drug Targets (2005) 1.59
Detection of phospholipid phase separation. A multifrequency phase fluorimetry study of 1,6-diphenyl-1,3,5-hexatriene fluorescence. J Biol Chem (1984) 1.58
Application of molecular methods for detection and transmission analysis of mycobacterium tuberculosis drug resistance in patients attending a reference hospital in Italy. J Infect Dis (1999) 1.56
Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas. J Clin Oncol (2000) 1.55
Leishmania in SLE mimicking an exacerbation. Clin Exp Rheumatol (2006) 1.54
Special factors in biological strings. J Theor Biol (2000) 1.51
Disposition of metformin (N,N-dimethylbiguanide) in man. Clin Pharmacol Ther (1978) 1.50
Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. AIDS (1995) 1.47
Antibody response to Helicobacter pylori CagA and heat-shock proteins in determining the risk of gastric cancer development. Dig Liver Dis (2001) 1.46
p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res (1994) 1.46
The role of EGF-related peptides in tumor growth. Front Biosci (2001) 1.45
Routine use of PCR-reverse cross-blot hybridization assay for rapid identification of Mycobacterium species growing in liquid media. J Clin Microbiol (1998) 1.43
Inward rectifier potassium channels in plants differ from their animal counterparts in response to voltage and channel modulators. Eur Biophys J (1995) 1.42
Structure of the squid axon membrane as derived from charge-pulse relaxation studies in the presence of absorbed lipophilic ions. J Membr Biol (1981) 1.42
Time-resolved fluorescence emission spectra of Laurdan in phospholipid vesicles by multifrequency phase and modulation fluorometry. Cell Mol Biol (1986) 1.41
Evidence for the detrimental role of proteolysis during liver preservation in humans. Gastroenterology (1995) 1.40
Biological activity of chitosan: ultrastructural study. Biomaterials (1988) 1.39
Nerve fiber behaviour in heavy water under voltage-clamp. Biophysik (1968) 1.39
Does HHV-8 have a protective role on the development of HIV encephalopathy? Italian HIV-Seroconversion Study. Neurology (1999) 1.38
Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011. Clin Infect Dis (2012) 1.36
Pressure dependence of sodium gating currents in the squid giant axon. Eur Biophys J (1984) 1.36
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts. Infection (2009) 1.33
Patient-reported nonadherence to HAART is related to protease inhibitor levels. J Acquir Immune Defic Syndr (2000) 1.31
Pressure dependence of the potassium currents of squid giant axon. J Membr Biol (1982) 1.31
Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology (1997) 1.31
Diagnosis of Pneumocystis carinii pneumonia: specificity and sensitivity of polymerase chain reaction in comparison with immunofluorescence in bronchoalveolar lavage specimens. J Med Microbiol (1993) 1.29
Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther (2004) 1.28
PCR detection of Toxoplasma gondii DNA in CSF for the differential diagnosis of AIDS-related focal brain lesions. J Med Microbiol (1996) 1.27
Non-stationary fluctuations of the potassium conductance at the node of ranvier of the frog. J Physiol (1984) 1.25
Impairment of skeletal muscle adenosine triphosphate-sensitive K+ channels in patients with hypokalemic periodic paralysis. J Clin Invest (1999) 1.25
Pharmacological characterization of chloride channels belonging to the ClC family by the use of chiral clofibric acid derivatives. Mol Pharmacol (2000) 1.24
Generating diversity at GABAergic synapses. Trends Neurosci (2001) 1.24
GAT-1, a high-affinity GABA plasma membrane transporter, is localized to neurons and astroglia in the cerebral cortex. J Neurosci (1995) 1.21
Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. Mucosal Immunol (2009) 1.20
Drastic reduction of the slow gate of human muscle chloride channel (ClC-1) by mutation C277S. J Physiol (2001) 1.20
The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter. Cancer Res (1998) 1.18
Duchenne muscular dystrophy: focus on pharmaceutical and nutritional interventions. Int J Biochem Cell Biol (2006) 1.18
Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis. Eur J Pediatr (2001) 1.18
Helicobacter pylori infection in patients affected by insulin-dependent diabetes mellitus. Eur J Gastroenterol Hepatol (1998) 1.16
Wrist joint involvement in systemic lupus erythematosus. An ultrasonographic study. Clin Exp Rheumatol (2004) 1.16
Cardiac involvement in patients with Wegener's granulomatosis. Rheumatol Int (2000) 1.14
Zoledronic acid blocks the interaction between mesenchymal stem cells and breast cancer cells: implications for adjuvant therapy of breast cancer. Ann Oncol (2011) 1.13
Recording of gating currents from Xenopus oocytes and gating noise analysis. Methods Enzymol (1992) 1.13
Acetazolamide opens the muscular KCa2+ channel: a novel mechanism of action that may explain the therapeutic effect of the drug in hypokalemic periodic paralysis. Ann Neurol (2000) 1.13
Discovery of powerful gamma-ray flares from the Crab Nebula. Science (2011) 1.13
Dynamics of extracellular release of Aspergillus fumigatus DNA and galactomannan during growth in blood and serum. J Med Microbiol (2009) 1.13
Nerve membrane electrical characteristics near the resting state. Biophysik (1970) 1.12
Gating and flickery block differentially affected by rubidium in homomeric KCNQ1 and heteromeric KCNQ1/KCNE1 potassium channels. Biophys J (2000) 1.12
Influence of partial hepatectomy on the induction of liver microsomal drug-metabolizing enzymes produced by phenobarbital. A biochemical and ultrastructural study. Lab Invest (1970) 1.12
Heterogeneity of glutamatergic and GABAergic release machinery in cerebral cortex. Neuroscience (2007) 1.12
PISSLRE, a human novel CDC2-related protein kinase. Oncogene (1994) 1.12
Gefitinib inhibits the ability of human bone marrow stromal cells to induce osteoclast differentiation: implications for the pathogenesis and treatment of bone metastasis. Endocr Relat Cancer (2005) 1.12
A pure primary squamous cell breast carcinoma presenting as a breast abscess: case report and review of literature. Ann Ital Chir (2004) 1.10
Physical interaction between CDK9 and B-Myb results in suppression of B-Myb gene autoregulation. Oncogene (2000) 1.10
Potassium and sodium current noise from squid axon membranes. Fed Proc (1975) 1.09
GAT-3, a high-affinity GABA plasma membrane transporter, is localized to astrocytic processes, and it is not confined to the vicinity of GABAergic synapses in the cerebral cortex. J Neurosci (1996) 1.09
The block of Shaker K+ channels by kappa-conotoxin PVIIA is state dependent. J Gen Physiol (1999) 1.09
Relationship between cutaneous and pulmonary involvement in systemic sclerosis. J Rheumatol (1997) 1.09
Random lasing and weak localization of light in dye-doped nematic liquid crystals. Opt Express (2006) 1.09
Muscle loading modulates aquaporin-4 expression in skeletal muscle. FASEB J (2001) 1.09
Prognostic value of immunohistochemical expression of p53, bax, Bcl-2 and Bcl-xL in resected non-small-cell lung cancers. Histopathology (2004) 1.08
Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) imaging for the diagnosis of cirrhosis during liver ultrasonography. Ultraschall Med (2011) 1.08
RASopathies: Clinical Diagnosis in the First Year of Life. Mol Syndromol (2011) 1.07
Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era. J Neurovirol (2001) 1.07